| Product Code: ETC7205768 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Finland saw significant import shipments of pregabalin from top exporting countries including Netherlands, Czechia, China, India, and Metropolitan France. The Herfindahl-Hirschman Index (HHI) indicated a shift from very high concentration in 2023 to high concentration in 2024, reflecting changing market dynamics. Despite a compound annual growth rate (CAGR) of -0.74% from 2020 to 2024, there was a notable decline in growth rate from 2023 to 2024 at -16.58%. This data suggests a complex landscape for pregabalin imports in Finland, signaling a potential need for market adaptation and strategic planning.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Finland Pregabalin Market Overview |
3.1 Finland Country Macro Economic Indicators |
3.2 Finland Pregabalin Market Revenues & Volume, 2021 & 2031F |
3.3 Finland Pregabalin Market - Industry Life Cycle |
3.4 Finland Pregabalin Market - Porter's Five Forces |
3.5 Finland Pregabalin Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Finland Pregabalin Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Finland Pregabalin Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Finland Pregabalin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic pain conditions in Finland |
4.2.2 Growing awareness and acceptance of pregabalin as an effective treatment for various neurological disorders |
4.2.3 Favorable government regulations and policies promoting access to healthcare services |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval and marketing in Finland |
4.3.2 Competition from alternative treatments and therapies for neurological disorders |
5 Finland Pregabalin Market Trends |
6 Finland Pregabalin Market, By Types |
6.1 Finland Pregabalin Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Finland Pregabalin Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Finland Pregabalin Market Revenues & Volume, By Epilepsy, 2021- 2031F |
6.1.4 Finland Pregabalin Market Revenues & Volume, By Neuropathic Pain, 2021- 2031F |
6.1.5 Finland Pregabalin Market Revenues & Volume, By Anxiety Disorder, 2021- 2031F |
6.1.6 Finland Pregabalin Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Finland Pregabalin Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Finland Pregabalin Market Revenues & Volume, By Fibromyalgia Agents, 2021- 2031F |
6.2.3 Finland Pregabalin Market Revenues & Volume, By Anticonvulsants, 2021- 2031F |
6.2.4 Finland Pregabalin Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Finland Pregabalin Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Finland Pregabalin Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.3 Finland Pregabalin Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.3.4 Finland Pregabalin Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.3.5 Finland Pregabalin Market Revenues & Volume, By Others, 2021- 2031F |
7 Finland Pregabalin Market Import-Export Trade Statistics |
7.1 Finland Pregabalin Market Export to Major Countries |
7.2 Finland Pregabalin Market Imports from Major Countries |
8 Finland Pregabalin Market Key Performance Indicators |
8.1 Number of prescriptions of pregabalin by healthcare providers in Finland |
8.2 Patient adherence rates to pregabalin treatment regimens |
8.3 Number of clinical trials and research studies conducted on pregabalin in Finland |
8.4 Percentage of healthcare professionals recommending pregabalin as a treatment option for neurological disorders |
8.5 Patient satisfaction and reported outcomes with pregabalin treatment |
9 Finland Pregabalin Market - Opportunity Assessment |
9.1 Finland Pregabalin Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Finland Pregabalin Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Finland Pregabalin Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Finland Pregabalin Market - Competitive Landscape |
10.1 Finland Pregabalin Market Revenue Share, By Companies, 2024 |
10.2 Finland Pregabalin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here